½ÃÀ庸°í¼­
»óǰÄÚµå
1566256

¼¼°èÀÇ ¸ÞÆ®Æ÷¸£¹Î ¿°»ê¿° ½ÃÀå(-2030³â)

Global Metformin Hydrochloride Market Insights, Forecast to 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: QYResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¸ÞÆ®Æ÷¸£¹Î ¿°»ê¿° ½ÃÀå ±Ô¸ð´Â 2023³â 3¾ï 9,405¸¸ ´Þ·¯¿¡¼­ ¿¹Ãø ±â°£ µ¿¾È 5.9%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 5¾ï 9,284¸¸ ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼°è ¸ÞÆ®Æ÷¸£¹Î ¿°»ê¿°(Metformin Hydrochloride) ½ÃÀåÀ» Á¶»çÇßÀ¸¸ç, ½ÃÀå °³¿ä, ½ÃÀå ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â °¢Á¾ ¿µÇâ¿äÀÎ ºÐ¼®, ½ÃÀå ±Ô¸ð ÃßÀÌ¿Í ¿¹Ãø, À¯Çüº°-¿ëµµº° ºÐ¼®, Áö¿ªº°-ÁÖ¿ä ±¹°¡º° »ó¼¼ ºÐ¼®, °æÀï ȯ°æ, ½ÃÀå Á¡À¯À², ÁÖ¿ä ±â¾÷ °³¿ä µîÀÇ Á¤º¸¸¦ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹üÀ§

  • ¸ÞƮȣ¸£¹Î ¿°»ê¿° : Á¦Ç° °³¿ä
  • À¯Çüº° ½ÃÀå
    • ½ÃÀå ±Ô¸ð : 2019³â vs. 2023³â vs. 2030³â
    • ¸ÞƮȣ¸£¹Î HCL
    • ¸ÞƮȣ¸£¹Î DC
  • ¿ëµµº° ½ÃÀå
    • ½ÃÀå ±Ô¸ð : 2019³â vs. 2023³â vs. 2030³â
    • Á¤Á¦
    • ¼­¹æÁ¤Á¦
  • ÀüÁ¦¿Í Á¦ÇÑ
  • Á¶»ç ¸ñÀû
  • Á¶»ç ´ë»ó³âµµ

Á¦2Àå ¼¼°èÀÇ ¸ÞƮȣ¸£¹Î ¿°»ê¿° : Á¦Á¶ µ¿Çâ

  • ¼¼°èÀÇ Á¦Á¶´É·Â
  • ¼¼°èÀÇ Á¦Á¶·® : 2019³â vs. 2023³â vs. 2030³â
  • ¼¼°èÀÇ Á¦Á¶·® : Áö¿ªº°
    • Á¦Á¶·® ÃßÀÌ
    • Á¦Á¶·® ¿¹Ãø
    • Á¦Á¶·® ½ÃÀå Á¡À¯À²
  • À¯·´
  • Áß±¹
  • Àεµ

Á¦3Àå ÁÖ¿ä ¿ä¾à

  • ¼¼°èÀÇ ¸ÅÃâ ÃßÀÌ¡¤¿¹Ãø
  • ¼¼°èÀÇ ¸ÅÃâ : Áö¿ªº°
    • ¸ÅÃâ : 2019³â vs. 2023³â vs. 2030³â
    • ¸ÅÃâ ÃßÀÌ
    • ¸ÅÃâ ¿¹Ãø
    • ¸ÅÃâ Á¡À¯À²
  • ÆÇ¸Å·® ÃßÀÌ¡¤¿¹Ãø
  • ¼¼°èÀÇ ÆÇ¸Å·® : Áö¿ªº°
    • ÆÇ¸Å·® : 2019³â vs. 2023³â vs. 2030³â
    • ÆÇ¸Å·® ÃßÀÌ
    • ÆÇ¸Å·® ¿¹Ãø
    • ÆÇ¸Å·® Á¡À¯À²
  • ºÏ¹Ì
  • À¯·´
  • Áß±¹
  • ¾Æ½Ã¾Æ(Áß±¹ Á¦¿Ü)
  • ³²¹Ì
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦4Àå °æÀï ±¸µµ : ÁÖ¿ä ±â¾÷º°

  • ÆÇ¸Å·® : Á¦Á¶¾÷üº°
    • ÆÇ¸Å·® ÃßÀÌ
    • ÆÇ¸Å·® Á¡À¯À²
    • Á¦Á¶¾÷ü »óÀ§ 10°³»ç¡¤5°³»ç
  • ¸ÅÃâ : Á¦Á¶¾÷üº°
    • ¸ÅÃâ ÃßÀÌ
    • ¸ÅÃâ Á¡À¯À²
    • Á¦Á¶¾÷ü »óÀ§ 10°³»ç¡¤5°³»ç
  • ÆÇ¸Å °¡°Ý : Á¦Á¶¾÷üº°
  • ÁÖ¿ä ±â¾÷ : ¾÷°è ¼øÀ§
  • °æÀï ±¸µµ ºÐ¼®
  • ÁÖ¿ä Á¦Á¶¾÷ü : Á¦Á¶°ÅÁ¡ ºÐÆ÷ ¹× º»»ç
  • ÁÖ¿ä Á¦Á¶¾÷ü : Á¦°ø Á¦Ç° ¹× ¿ëµµ
  • ÁÖ¿ä Á¦Á¶¾÷ü : ¼³¸³ÀÏ
  • ÀμöÇÕº´(M&A), È®Àå °èȹ

Á¦5Àå ½ÃÀå ±Ô¸ð : À¯Çüº°

  • ÆÇ¸Å·® ÃßÀÌ¡¤¿¹Ãø¡¤½ÃÀå Á¡À¯À²
  • ¸ÅÃâ ÃßÀÌ¡¤¿¹Ãø¡¤½ÃÀå Á¡À¯À²
  • °¡°Ý ÃßÀÌ¡¤¿¹Ãø

Á¦6Àå ½ÃÀå ±Ô¸ð : ¿ëµµº°

  • ÆÇ¸Å·® ÃßÀÌ¡¤¿¹Ãø¡¤½ÃÀå Á¡À¯À²
  • ¸ÅÃâ ÃßÀÌ¡¤¿¹Ãø¡¤½ÃÀå Á¡À¯À²
  • °¡°Ý ÃßÀÌ¡¤¿¹Ãø

Á¦7Àå ºÏ¹Ì

Á¦8Àå À¯·´

Á¦9Àå Áß±¹

Á¦10Àå ¾Æ½Ã¾Æ(Áß±¹ Á¦¿Ü)

Á¦11Àå ³²¹Ì

Á¦12Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦13Àå ±â¾÷ °³¿ä

  • Wanbury
  • USV
  • Shouguang Fukang Pharmaceutical
  • Vistin Pharma
  • CR Double-Crane
  • Keyuan Pharmaceutical
  • Farmhispania Group
  • Harman Finochem
  • Shijiazhuang Polee Pharmaceutical
  • Aarti Drugs
  • Exemed Pharmaceuticals

Á¦14Àå »ê¾÷ üÀΰú ÆÇ¸Åä³Î ºÐ¼®

  • »ê¾÷ üÀÎ ºÐ¼®
  • ÁÖ¿ä ¿øÀç·á
  • Á¦Á¶ ¹æ½Ä ¹× °øÁ¤
  • ÆÇ¸Å ¹× ¸¶ÄÉÆÃ
  • °í°´

Á¦15Àå ¸ÞÆ®È£¸£¹Î ¿°»ê¿° : ½ÃÀå ¿ªÇÐ

  • ¾÷°è µ¿Çâ
  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ

Á¦16Àå ¼¼°èÀÇ ¸ÞƮȣ¸£¹Î ¿°»ê¿° ½ÃÀå : ÁÖ¿ä Á¶»ç °á°ú

Á¦17Àå ºÎ·Ï

LSH 24.10.17

The Metformin Hydrochloride market was valued at US$ 394.05 million in 2023 and is projected to reach US$ 592.84 million by 2030, at a CAGR of 5.9% during the forecast period (2024-2030).

In terms of production side, this report researches the Metformin Hydrochloride production, growth rate, market share by manufacturers and by region (region level and country level), from 2019 to 2024, and forecast to 2030.

In terms of consumption side, this report focuses on the sales of Metformin Hydrochloride by region (region level and country level), by company, by Type and by Application. From 2019 to 2024 and forecast to 2030.

Report Includes:

This report presents an overview of global market for Metformin Hydrochloride, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Metformin Hydrochloride, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Metformin Hydrochloride, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Metformin Hydrochloride sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Metformin Hydrochloride market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Metformin Hydrochloride sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Wanbury, USV, Shouguang Fukang Pharmaceutical, Vistin Pharma, CR Double-Crane, Keyuan Pharmaceutical, Farmhispania Group, Harman Finochem, Shijiazhuang Polee Pharmaceutical, Aarti Drugs, etc.

Market Segmentation

By Company

  • Wanbury
  • USV
  • Shouguang Fukang Pharmaceutical
  • Vistin Pharma
  • CR Double-Crane
  • Keyuan Pharmaceutical
  • Farmhispania Group
  • Harman Finochem
  • Shijiazhuang Polee Pharmaceutical
  • Aarti Drugs
  • Exemed Pharmaceuticals

Segment by Type

  • Metformin HCL
  • Metformin DC

Segment by Application

  • Metformin Hydrochloride Tablets
  • Metformin Hydrochloride Extended-Release Tablets
  • Others

Production by Region

  • Europe
  • China
  • India

Sales by Region

North America

  • U.S.
  • Canada
  • Mexico

Asia

  • China
  • Japan
  • Korea
  • India
  • Southeast Asia

Europe

  • Germany
  • France
  • U.K.
  • Italy
  • Spain

Middle East, Africa

  • Turkey
  • Iran
  • South Africa

South America

  • Brazil
  • Argentina

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Metformin Hydrochloride production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.

Chapter 3: Sales (consumption), revenue of Metformin Hydrochloride in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Metformin Hydrochloride manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: North America (North America) by Type, by Application and by country, sales, and revenue for each segment.

Chapter 8: Europe by Type, by Application and by country, sales, and revenue for each segment.

Chapter 9: China by Type, and by Application, sales, and revenue for each segment.

Chapter 10: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.

Chapter 11: South America by Type, by Application and by country, sales, and revenue for each segment.

Chapter 12: Middle East, Africa by Type, by Application and by country, sales, and revenue for each segment.

Chapter 13: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Metformin Hydrochloride sales, revenue, price, gross margin, and recent development, etc.

Chapter 14: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 15: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 16: The main points and conclusions of the report.

Table of Contents

1 Study Coverage

  • 1.1 Metformin Hydrochloride Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Metformin Hydrochloride Market Size by Type, 2019 VS 2023 VS 2030
    • 1.2.2 Metformin HCL
    • 1.2.3 Metformin DC
  • 1.3 Market by Application
    • 1.3.1 Global Metformin Hydrochloride Market Size by Application, 2019 VS 2023 VS 2030
    • 1.3.2 Metformin Hydrochloride Tablets
    • 1.3.3 Metformin Hydrochloride Extended-Release Tablets
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Metformin Hydrochloride Production

  • 2.1 Global Metformin Hydrochloride Production Capacity (2019-2030)
  • 2.2 Global Metformin Hydrochloride Production by Region: 2019 VS 2023 VS 2030
  • 2.3 Global Metformin Hydrochloride Production by Region
    • 2.3.1 Global Metformin Hydrochloride Historic Production by Region (2019-2024)
    • 2.3.2 Global Metformin Hydrochloride Forecasted Production by Region (2025-2030)
    • 2.3.3 Global Metformin Hydrochloride Production Market Share by Region (2019-2030)
  • 2.4 Europe
  • 2.5 China
  • 2.6 India

3 Executive Summary

  • 3.1 Global Metformin Hydrochloride Revenue Estimates and Forecasts 2019-2030
  • 3.2 Global Metformin Hydrochloride Revenue by Region
    • 3.2.1 Global Metformin Hydrochloride Revenue by Region: 2019 VS 2023 VS 2030
    • 3.2.2 Global Metformin Hydrochloride Revenue by Region (2019-2024)
    • 3.2.3 Global Metformin Hydrochloride Revenue by Region (2025-2030)
    • 3.2.4 Global Metformin Hydrochloride Revenue Market Share by Region (2019-2030)
  • 3.3 Global Metformin Hydrochloride Sales Estimates and Forecasts 2019-2030
  • 3.4 Global Metformin Hydrochloride Sales by Region
    • 3.4.1 Global Metformin Hydrochloride Sales by Region: 2019 VS 2023 VS 2030
    • 3.4.2 Global Metformin Hydrochloride Sales by Region (2019-2024)
    • 3.4.3 Global Metformin Hydrochloride Sales by Region (2025-2030)
    • 3.4.4 Global Metformin Hydrochloride Sales Market Share by Region (2019-2030)
  • 3.5 North America
  • 3.6 Europe
  • 3.7 China
  • 3.8 Asia (excluding China)
  • 3.9 South America
  • 3.10 Middle East, Africa

4 Competition by Manufacturers

  • 4.1 Global Metformin Hydrochloride Sales by Manufacturers
    • 4.1.1 Global Metformin Hydrochloride Sales by Manufacturers (2019-2024)
    • 4.1.2 Global Metformin Hydrochloride Sales Market Share by Manufacturers (2019-2024)
    • 4.1.3 Global Top 10 and Top 5 Largest Manufacturers of Metformin Hydrochloride in 2023
  • 4.2 Global Metformin Hydrochloride Revenue by Manufacturers
    • 4.2.1 Global Metformin Hydrochloride Revenue by Manufacturers (2019-2024)
    • 4.2.2 Global Metformin Hydrochloride Revenue Market Share by Manufacturers (2019-2024)
    • 4.2.3 Global Top 10 and Top 5 Companies by Metformin Hydrochloride Revenue in 2023
  • 4.3 Global Metformin Hydrochloride Sales Price by Manufacturers (2019-2024)
  • 4.4 Global Key Players of Metformin Hydrochloride, Industry Ranking, 2022 VS 2023
  • 4.5 Analysis of Competitive Landscape
    • 4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 4.5.2 Global Metformin Hydrochloride Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 4.6 Global Key Manufacturers of Metformin Hydrochloride, Manufacturing Base Distribution and Headquarters
  • 4.7 Global Key Manufacturers of Metformin Hydrochloride, Product Offered and Application
  • 4.8 Global Key Manufacturers of Metformin Hydrochloride Established
  • 4.9 Mergers & Acquisitions, Expansion Plans

5 Market Size by Type

  • 5.1 Global Metformin Hydrochloride Sales by Type
    • 5.1.1 Global Metformin Hydrochloride Historical Sales by Type (2019-2024)
    • 5.1.2 Global Metformin Hydrochloride Forecasted Sales by Type (2025-2030)
    • 5.1.3 Global Metformin Hydrochloride Sales Market Share by Type (2019-2030)
  • 5.2 Global Metformin Hydrochloride Revenue by Type
    • 5.2.1 Global Metformin Hydrochloride Historical Revenue by Type (2019-2024)
    • 5.2.2 Global Metformin Hydrochloride Forecasted Revenue by Type (2025-2030)
    • 5.2.3 Global Metformin Hydrochloride Revenue Market Share by Type (2019-2030)
  • 5.3 Global Metformin Hydrochloride Price by Type
    • 5.3.1 Global Metformin Hydrochloride Price by Type (2019-2024)
    • 5.3.2 Global Metformin Hydrochloride Price Forecast by Type (2025-2030)

6 Market Size by Application

  • 6.1 Global Metformin Hydrochloride Sales by Application
    • 6.1.1 Global Metformin Hydrochloride Historical Sales by Application (2019-2024)
    • 6.1.2 Global Metformin Hydrochloride Forecasted Sales by Application (2025-2030)
    • 6.1.3 Global Metformin Hydrochloride Sales Market Share by Application (2019-2030)
  • 6.2 Global Metformin Hydrochloride Revenue by Application
    • 6.2.1 Global Metformin Hydrochloride Historical Revenue by Application (2019-2024)
    • 6.2.2 Global Metformin Hydrochloride Forecasted Revenue by Application (2025-2030)
    • 6.2.3 Global Metformin Hydrochloride Revenue Market Share by Application (2019-2030)
  • 6.3 Global Metformin Hydrochloride Price by Application
    • 6.3.1 Global Metformin Hydrochloride Price by Application (2019-2024)
    • 6.3.2 Global Metformin Hydrochloride Price Forecast by Application (2025-2030)

7 North America

  • 7.1 North America Metformin Hydrochloride Market Size by Type
    • 7.1.1 North America Metformin Hydrochloride Sales by Type (2019-2030)
    • 7.1.2 North America Metformin Hydrochloride Revenue by Type (2019-2030)
  • 7.2 North America Metformin Hydrochloride Market Size by Application
    • 7.2.1 North America Metformin Hydrochloride Sales by Application (2019-2030)
    • 7.2.2 North America Metformin Hydrochloride Revenue by Application (2019-2030)
  • 7.3 North America Metformin Hydrochloride Market Size by Country
    • 7.3.1 North America Metformin Hydrochloride Revenue by Country: 2019 VS 2023 VS 2030
    • 7.3.2 North America Metformin Hydrochloride Revenue by Country (2019-2030)
    • 7.3.3 North America Metformin Hydrochloride Sales by Country (2019-2030)
    • 7.3.4 US
    • 7.3.5 Canada
    • 7.3.6 Mexico

8 Europe

  • 8.1 Europe Metformin Hydrochloride Market Size by Type
    • 8.1.1 Europe Metformin Hydrochloride Sales by Type (2019-2030)
    • 8.1.2 Europe Metformin Hydrochloride Revenue by Type (2019-2030)
  • 8.2 Europe Metformin Hydrochloride Market Size by Application
    • 8.2.1 Europe Metformin Hydrochloride Sales by Application (2019-2030)
    • 8.2.2 Europe Metformin Hydrochloride Revenue by Application (2019-2030)
  • 8.3 Europe Metformin Hydrochloride Market Size by Country
    • 8.3.1 Europe Metformin Hydrochloride Revenue by Country: 2019 VS 2023 VS 2030
    • 8.3.2 Europe Metformin Hydrochloride Sales by Country (2019-2030)
    • 8.3.3 Europe Metformin Hydrochloride Revenue by Country (2019-2030)
    • 8.3.4 Germany
    • 8.3.5 France
    • 8.3.6 U.K.
    • 8.3.7 Italy
    • 8.3.8 Spain

9 China

  • 9.1 China Metformin Hydrochloride Market Size by Type
    • 9.1.1 China Metformin Hydrochloride Sales by Type (2019-2030)
    • 9.1.2 China Metformin Hydrochloride Revenue by Type (2019-2030)
  • 9.2 China Metformin Hydrochloride Market Size by Application
    • 9.2.1 China Metformin Hydrochloride Sales by Application (2019-2030)
    • 9.2.2 China Metformin Hydrochloride Revenue by Application (2019-2030)

10 Asia (excluding China)

  • 10.1 Asia Metformin Hydrochloride Market Size by Type
    • 10.1.1 Asia Metformin Hydrochloride Sales by Type (2019-2030)
    • 10.1.2 Asia Metformin Hydrochloride Revenue by Type (2019-2030)
  • 10.2 Asia Metformin Hydrochloride Market Size by Application
    • 10.2.1 Asia Metformin Hydrochloride Sales by Application (2019-2030)
    • 10.2.2 Asia Metformin Hydrochloride Revenue by Application (2019-2030)
  • 10.3 Asia Metformin Hydrochloride Market Size by Region
    • 10.3.1 Asia Metformin Hydrochloride Revenue by Region: 2019 VS 2023 VS 2030
    • 10.3.2 Asia Metformin Hydrochloride Revenue by Region (2019-2030)
    • 10.3.3 Asia Metformin Hydrochloride Sales by Region (2019-2030)
    • 10.3.4 Japan
    • 10.3.5 South Korea
    • 10.3.6 Southeast Asia
    • 10.3.7 India

11 South America

  • 11.1 South America Metformin Hydrochloride Market Size by Type
    • 11.1.1 South America Metformin Hydrochloride Sales by Type (2019-2030)
    • 11.1.2 South America Metformin Hydrochloride Revenue by Type (2019-2030)
  • 11.2 South America Metformin Hydrochloride Market Size by Application
    • 11.2.1 South America Metformin Hydrochloride Sales by Application (2019-2030)
    • 11.2.2 South America Metformin Hydrochloride Revenue by Application (2019-2030)
  • 11.3 South America Metformin Hydrochloride Market Size by Country
    • 11.3.1 South America Metformin Hydrochloride Revenue by Country: 2018 VS 2022 VS 2030
    • 11.3.2 South America Metformin Hydrochloride Revenue by Country (2019-2030)
    • 11.3.3 South America Metformin Hydrochloride Sales by Country (2019-2030)
    • 11.3.4 Brazil
    • 11.3.5 Argentina

12 Middle East and Africa

  • 12.1 Middle East and Africa Metformin Hydrochloride Market Size by Type
    • 12.1.1 Middle East and Africa Metformin Hydrochloride Sales by Type (2019-2030)
    • 12.1.2 Middle East and Africa Metformin Hydrochloride Revenue by Type (2019-2030)
  • 12.2 Middle East and Africa Metformin Hydrochloride Market Size by Application
    • 12.2.1 Middle East and Africa Metformin Hydrochloride Sales by Application (2019-2030)
    • 12.2.2 Middle East and Africa Metformin Hydrochloride Revenue by Application (2019-2030)
  • 12.3 Middle East and Africa Metformin Hydrochloride Market Size by Country
    • 12.3.1 Middle East and Africa Metformin Hydrochloride Revenue by Country: 2018 VS 2022 VS 2030
    • 12.3.2 Middle East and Africa Metformin Hydrochloride Revenue by Country (2019-2030)
    • 12.3.3 Middle East and Africa Metformin Hydrochloride Sales by Country (2019-2030)
    • 12.3.4 Turkey
    • 12.3.5 Iran

13 Corporate Profile

  • 13.1 Wanbury
    • 13.1.1 Wanbury Corporation Information
    • 13.1.2 Wanbury Overview
    • 13.1.3 Wanbury Metformin Hydrochloride Sales, Price, Revenue and Gross Margin (2019-2024)
    • 13.1.4 Wanbury Metformin Hydrochloride Product Description
    • 13.1.5 Wanbury Recent Developments
  • 13.2 USV
    • 13.2.1 USV Corporation Information
    • 13.2.2 USV Overview
    • 13.2.3 USV Metformin Hydrochloride Sales, Price, Revenue and Gross Margin (2019-2024)
    • 13.2.4 USV Metformin Hydrochloride Product Description
    • 13.2.5 USV Recent Developments
  • 13.3 Shouguang Fukang Pharmaceutical
    • 13.3.1 Shouguang Fukang Pharmaceutical Corporation Information
    • 13.3.2 Shouguang Fukang Pharmaceutical Overview
    • 13.3.3 Shouguang Fukang Pharmaceutical Metformin Hydrochloride Sales, Price, Revenue and Gross Margin (2019-2024)
    • 13.3.4 Shouguang Fukang Pharmaceutical Metformin Hydrochloride Product Description
    • 13.3.5 Shouguang Fukang Pharmaceutical Recent Developments
  • 13.4 Vistin Pharma
    • 13.4.1 Vistin Pharma Corporation Information
    • 13.4.2 Vistin Pharma Overview
    • 13.4.3 Vistin Pharma Metformin Hydrochloride Sales, Price, Revenue and Gross Margin (2019-2024)
    • 13.4.4 Vistin Pharma Metformin Hydrochloride Product Description
    • 13.4.5 Vistin Pharma Recent Developments
  • 13.5 CR Double-Crane
    • 13.5.1 CR Double-Crane Corporation Information
    • 13.5.2 CR Double-Crane Overview
    • 13.5.3 CR Double-Crane Metformin Hydrochloride Sales, Price, Revenue and Gross Margin (2019-2024)
    • 13.5.4 CR Double-Crane Metformin Hydrochloride Product Description
    • 13.5.5 CR Double-Crane Recent Developments
  • 13.6 Keyuan Pharmaceutical
    • 13.6.1 Keyuan Pharmaceutical Corporation Information
    • 13.6.2 Keyuan Pharmaceutical Overview
    • 13.6.3 Keyuan Pharmaceutical Metformin Hydrochloride Sales, Price, Revenue and Gross Margin (2019-2024)
    • 13.6.4 Keyuan Pharmaceutical Metformin Hydrochloride Product Description
    • 13.6.5 Keyuan Pharmaceutical Recent Developments
  • 13.7 Farmhispania Group
    • 13.7.1 Farmhispania Group Corporation Information
    • 13.7.2 Farmhispania Group Overview
    • 13.7.3 Farmhispania Group Metformin Hydrochloride Sales, Price, Revenue and Gross Margin (2019-2024)
    • 13.7.4 Farmhispania Group Metformin Hydrochloride Product Description
    • 13.7.5 Farmhispania Group Recent Developments
  • 13.8 Harman Finochem
    • 13.8.1 Harman Finochem Corporation Information
    • 13.8.2 Harman Finochem Overview
    • 13.8.3 Harman Finochem Metformin Hydrochloride Sales, Price, Revenue and Gross Margin (2019-2024)
    • 13.8.4 Harman Finochem Metformin Hydrochloride Product Description
  • 13.9 Shijiazhuang Polee Pharmaceutical
    • 13.9.1 Shijiazhuang Polee Pharmaceutical Corporation Information
    • 13.9.2 Shijiazhuang Polee Pharmaceutical Overview
    • 13.9.3 Shijiazhuang Polee Pharmaceutical Metformin Hydrochloride Sales, Price, Revenue and Gross Margin (2019-2024)
    • 13.9.4 Shijiazhuang Polee Pharmaceutical Metformin Hydrochloride Product Description
  • 13.10 Aarti Drugs
    • 13.10.1 Aarti Drugs Corporation Information
    • 13.10.2 Aarti Drugs Overview
    • 13.10.3 Aarti Drugs Metformin Hydrochloride Sales, Price, Revenue and Gross Margin (2019-2024)
    • 13.10.4 Aarti Drugs Metformin Hydrochloride Product Description
  • 13.11 Exemed Pharmaceuticals
    • 13.11.1 Exemed Pharmaceuticals Corporation Information
    • 13.11.2 Exemed Pharmaceuticals Overview
    • 13.11.3 Exemed Pharmaceuticals Metformin Hydrochloride Sales, Price, Revenue and Gross Margin (2019-2024)
    • 13.11.4 Exemed Pharmaceuticals Metformin Hydrochloride Product Description

14 Industry Chain and Sales Channels Analysis

  • 14.1 Metformin Hydrochloride Industry Chain Analysis
  • 14.2 Metformin Hydrochloride Key Raw Materials
    • 14.2.1 Key Raw Materials
    • 14.2.2 Raw Materials Key Suppliers
  • 14.3 Metformin Hydrochloride Production Mode & Process
  • 14.4 Metformin Hydrochloride Sales and Marketing
  • 14.5 Metformin Hydrochloride Customers

15 Metformin Hydrochloride Market Dynamics

    • 15.1.1 Metformin Hydrochloride Industry Trends
    • 15.1.2 Metformin Hydrochloride Market Drivers
    • 15.1.3 Metformin Hydrochloride Market Challenges
    • 15.1.4 Metformin Hydrochloride Market Restraints

16 Key Findings in the Global Metformin Hydrochloride Study

17 Appendix

  • 17.1 Research Methodology
    • 17.1.1 Methodology/Research Approach
    • 17.1.2 Data Source
  • 17.2 Author Details 164
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦